Abstract:Cancer therapy targets specific metabolic pathways or a single gene. This may result in low therapeutic effects due to drug selectivity and drug resistance. Recent studies revealed that the mitochondrial membrane potential and transmembrane permeability of cancerous mitochondria are differed from normal mitochondria. Thus, chemotherapy targeting cancerous mitochondria could be an innovative and competent strategy for cancer therapy. Previously, our work with a novel group of mitochondria targeting small molecules presented promising inhibitory capability toward various cancer cell lines and suppressed adenosine triphosphate (ATP) generation. Therefore, it is critical to understand the anticancer effect and targeting mechanism of these small molecules. This study investigated the inhibitory activity of mitochondria targeting small molecules with human cervical cancer cells - HeLa to further explore their therapeutic potential. HeLa cells were exposed to 10 mu M of syn-thesized compounds and presented elevation in intracellular reactive oxygen species (ROS) level, impaired mitochondrial membrane potential and upregulation of apoptosis as well as necrosis. In vivo, HeLa cell tumor-bearing BALB/c nude mice were treated with mitochondria targeting small molecules for 12 days consecu-tively. Throughout this chemotherapy study, no deleterious side effects nor the appearance of toxicity was observed. Furthermore, mitochondria targeting small molecules treated groups exhibited significant down-regulation with both tumor volume and tumor weight compared to the Doxorubicin (DOX) treated group. Thus, inhibition of mitochondrial ATP synthesis, activation of intracellular ROS production, down-regulation of mitochondrial membrane potential and upregulation of apoptosis and necrosis rates are the indications of cancer therapy. In this work, we examined the anticancer capability of four mitochondria targeting small molecules in vitro and in vivo, and demonstrated a novel therapeutic approach in cancer therapy with tremendous potential.

A ROS-mediated Lysosomal–mitochondrial Pathway is Induced by a Novel Amonafide Analogue, 7c, in Human Hela Cervix Carcinoma Cells

Novel camphor-based pyrimidine derivatives induced cancer cell death through a ROS-mediated mitochondrial apoptosis pathway

Nimotuzumab and irinotecan synergistically induce ROS‐mediated apoptosis by endoplasmic reticulum stress and mitochondrial‐mediated pathway in cervical cancer

Antiproliferative and Apoptosis-Inducing Activities of Novel Naphthalimide–cyclam Conjugates Through Dual Topoisomerase (topo) I/II Inhibition

Target ROS to Induce Apoptosis and Cell Cycle Arrest by 5,7-Dimethoxy-1,4-naphthoquinone Derivative

Design, Synthesis, and In Vitro Cytotoxic Studies of Some Novel Arylidene-Hydrazinyl-Thiazoles as Anticancer and Apoptosis-Inducing Agents

7-b, a novel amonafide analogue, cause growth inhibition and apoptosis in Raji cells via a ROS-mediated mitochondrial pathway.

A new class of naphthalimide-based antitumor agents that inhibit topoisomerase II and induce lysosomal membrane permeabilization and apoptosis.

Reactive Oxygen Species Mediate 6c-Induced Mitochondrial and Lysosomal Dysfunction, Autophagic Cell Death, and DNA Damage in Hepatocellular Carcinoma

Design, synthesis and anti-tumor activity of novel benzothiophenonaphthalimide derivatives targeting mitochondrial DNA (mtDNA) G-quadruplex

Mitochondrial Targeting Derivatives of Honokiol Enhanced Selective Antitumor Activity in Nci-H446 Cellsand Decreased in Vivo Toxicity in Caenorhabditis Elegans

Biological Evaluation of Mitochondria Targeting Small Molecules As Potent Anticancer Drugs.

Novel N-Substituted 2-(2-(adamantan-1-yl)-1h-indol-3-yl)-2-oxoacetamide Derivatives: Synthesis and Biological Evaluation

Induction of Apoptosis and Suppression of ERCC1 Expression by the Potent Amonafide Analogue 8-C in Human Colorectal Carcinoma Cells.

Synthesis of Selenazolopyridine Derivatives with Capability to Induce Apoptosis in Human Breast Carcinoma MCF-7 Cells Through Scavenge of Intracellular ROS.

Novel naphthalimide-benzoic acid conjugates as potential apoptosis-inducing agents: design, synthesis, and biological activity.

Antiproliferative Evaluation of Novel 4-Imidazolidinone Derivatives as Anticancer Agent Which Triggers ROS-Dependent Apoptosis in Colorectal Cancer Cell

A Novel 7‐azaisoindigo Derivative‐induced Cancer Cell Apoptosis and Mitochondrial Dysfunction Mediated by Oxidative Stress

R16, a Novel Amonafide Analogue, Induces Apoptosis and G2-M Arrest Via Poisoning Topoisomerase II

A Small Molecule Inhibitor of the UBE2F-CRL5 Axis Induces Apoptosis and Radiosensitization in Lung Cancer

Discovery Of Novel Bromophenol Hybrids As Potential Anticancer Agents Through The Ros-Mediated Apoptotic Pathway: Design, Synthesis And Biological Evaluation